CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Photocoagulation Therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000131
NCT00000131Phase 3Completed
CompareCT.gov

Central Vein Occlusion Study (CVOS)

National Eye Institute (NEI)·interventional·Posted Sep 24, 1999·Updated Sep 17, 2009

In Brief

A Phase 3 clinical trial evaluating Photocoagulation Therapy for Retinal Vein Occlusion and Retinal Diseases. Completed.

Detailed Summary

To determine whether photocoagulation therapy can help prevent iris neovascularization in eyes with central vein occlusion (CVO) and evidence of ischemic retina. To assess whether grid-pattern photocoagulation therapy will reduce loss of central visual acuity due to macular edema secondary to CVO. To develop new data describing the course and prognosis for eyes with CVO.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinal Vein Occlusion, Retinal Diseases
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 24, 1999
Enrollment StartAug 1, 1988
Study CompletionFeb 1, 1994
TodayJul 2, 2026
Posted 26.8 years ago

Interventions

Photocoagulation Therapyprocedure